Viktor Kharitonin

Net worth over time

Biography

• Viktor Kharitonin created multinational pharmaceutical firm Pharmstandard with Russian billionaire Roman Abramovich and other partners in 2003 by combining five factories.
• Kharitonin and partner Egor Kulkov bought out the other investors in 2008, a year after Pharmstandard went public in London. They took Pharmstandard private again, eight years later.
• Kharitonin and Kulkov also hold stakes in other Russian pharmaceuticals companies: OTCPharm, Biocad and Generium, one of the producers of the COVID-19 vaccine Sputnik V.
• In 2022 The two partners tried to buy Russian assets of Austrian-British packaging and paper group Mondi for 1.5 billion euro, but Russian authorities rejected the deal.
• In 2023 Kharitonin and his partners bought Russian assets of German chemical producer Henkel for 600 million euros, leaving Henkel the option of buying back the business.
• In October 2014 Kharitonin became co-owner of Nurbugring in Germany, one of the oldest race tracks in Europe.
• The Novosibirsk State University graduate got his start selling consumer goods.